PepEvolutionSermorelin
Geref
The original FDA-approved GHRH analogue — stimulates endogenous GH physiologically, widely compounded off-label.
Verdict — B · Viable
A gentler, more physiologic GH-axis approach than exogenous HGH — FDA precedent, reasonable safety profile, and widely compounded. The off-label evidence is thinner than the approved indication; obtain from a licensed compounding pharmacy with a batch-specific COA.
Overview
Sermorelin is a GHRH (1-29) analogue FDA-approved in 1997 (Geref) for pediatric GH deficiency. It stimulates the pituitary to release endogenous GH rather than replacing it exogenously, producing a physiologic pulse rather than supraphysiologic levels. It is widely used off-label through compounding pharmacies for adult GH support and anti-aging. The clinical evidence for the approved pediatric indication is solid; the off-label adult body-composition evidence base is thinner. Compounding availability is broad and COA coverage is reasonable.
PepScore Breakdown — the four axes
Evidence
35% weightHow strong is the published human science?
Sourcing & COA
30% weightOur moatCan a buyer obtain an independently-verified, high-purity version? — our proprietary layer.
Safety & Risk
25% weightWhat is the real-world harm potential?
Practicality
10% weightHow easy is it to actually run a verified version?
Sources & Citations
Every claim cites a primary source. Citations are machine-audited against NCBI — see methodology.
Want a clinical path?
Talk to a licensed provider about Sermorelin and whether it's appropriate for your situation.
Talk to a Provider ↗Telehealth. Not medical advice — for educational purposes.
Get the PepEvolution Dispatch
Monthly COA findings, vendor changes, and new grades. Research/educational only — no spam.
Free. Unsubscribe anytime. Research/educational content only.
Educational only — not medical advice. PepScore is an educational research grade, not a prescription or dosing recommendation. Some vendor links are affiliate links — this never affects grades. Consult a licensed healthcare provider before using any compound.